IGFBP1 and type 2 diabetes mellitus: This non-randomized controlled trial aimed to compare the effects of the 5:2 diet during six months, with a 12-month follow-up on the insulin levels as the primary outcome and markers of insulin secretion (C-peptide and IGFBP-1) and sensitivity (HOMA-IR) and body composition as secondary outcomes in overweight/obese men and women with and without T2D.